190 related articles for article (PubMed ID: 24164540)
1. CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production.
Chen Y; Peng H; Chen Y; Wei H; Sun R; Tian Z
Immunology; 2014 Mar; 141(3):388-400. PubMed ID: 24164540
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
3. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production.
Lafdil F; Wang H; Park O; Zhang W; Moritoki Y; Yin S; Fu XY; Gershwin ME; Lian ZX; Gao B
Gastroenterology; 2009 Dec; 137(6):2125-35.e1-2. PubMed ID: 19686746
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
[TBL] [Abstract][Full Text] [Related]
5. Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis.
Zhao N; Hao J; Ni Y; Luo W; Liang R; Cao G; Zhao Y; Wang P; Zhao L; Tian Z; Flavell R; Hong Z; Han J; Yao Z; Wu Z; Yin Z
J Immunol; 2011 Nov; 187(10):5007-14. PubMed ID: 21987663
[TBL] [Abstract][Full Text] [Related]
6. γδ T cells are indispensable for interleukin-23-mediated protection against Concanavalin A-induced hepatitis in hepatitis B virus transgenic mice.
Meng Z; Wang J; Yuan Y; Cao G; Fan S; Gao C; Wang L; Li Z; Wu X; Wu Z; Zhao L; Yin Z
Immunology; 2017 May; 151(1):43-55. PubMed ID: 28092402
[TBL] [Abstract][Full Text] [Related]
7. Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice.
Chen J; Duan L; Xiong A; Zhang H; Zheng F; Tan Z; Gong F; Fang M
J Mol Med (Berl); 2012 Dec; 90(12):1505-15. PubMed ID: 22983503
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.
Fullerton AM; Roth RA; Ganey PE
Toxicol Sci; 2013 Nov; 136(1):72-85. PubMed ID: 23970800
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
[TBL] [Abstract][Full Text] [Related]
10. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Fiorucci S; Santucci L; Antonelli E; Distrutti E; Del Sero G; Morelli O; Romani L; Federici B; Del Soldato P; Morelli A
Gastroenterology; 2000 Feb; 118(2):404-21. PubMed ID: 10648469
[TBL] [Abstract][Full Text] [Related]
11. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
[TBL] [Abstract][Full Text] [Related]
12. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
13. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
[TBL] [Abstract][Full Text] [Related]
14. Lamina propria interleukin 17 A aggravates natural killer T-cell activation in autoimmune hepatitis.
Chen J; Li X; Zeng P; Zhang X; Bi K; Lin C; Jiang J; Diao H
FASEB J; 2022 Jun; 36(6):e22346. PubMed ID: 35583908
[TBL] [Abstract][Full Text] [Related]
15. Protective role of IL-33/ST2 axis in Con A-induced hepatitis.
Volarevic V; Mitrovic M; Milovanovic M; Zelen I; Nikolic I; Mitrovic S; Pejnovic N; Arsenijevic N; Lukic ML
J Hepatol; 2012 Jan; 56(1):26-33. PubMed ID: 21703183
[TBL] [Abstract][Full Text] [Related]
16. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis.
Kremer M; Hines IN; Milton RJ; Wheeler MD
Hepatology; 2006 Jul; 44(1):216-27. PubMed ID: 16799967
[TBL] [Abstract][Full Text] [Related]
17. NKG2A inhibits invariant NKT cell activation in hepatic injury.
Kawamura T; Takeda K; Kaneda H; Matsumoto H; Hayakawa Y; Raulet DH; Ikarashi Y; Kronenberg M; Yagita H; Kinoshita K; Abo T; Okumura K; Smyth MJ
J Immunol; 2009 Jan; 182(1):250-8. PubMed ID: 19109156
[TBL] [Abstract][Full Text] [Related]
18. Scavenger receptor A restrains T-cell activation and protects against concanavalin A-induced hepatic injury.
Zuo D; Yu X; Guo C; Wang H; Qian J; Yi H; Lu X; Lv ZP; Subjeck JR; Zhou H; Sanyal AJ; Chen Z; Wang XY
Hepatology; 2013 Jan; 57(1):228-38. PubMed ID: 22821642
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
Li B; Sun R; Wei H; Gao B; Tian Z
Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
[TBL] [Abstract][Full Text] [Related]
20. Glutathione peroxidase 1 deficiency attenuates concanavalin A-induced hepatic injury by modulation of T-cell activation.
Lee DH; Son DJ; Park MH; Yoon DY; Han SB; Hong JT
Cell Death Dis; 2016 Apr; 7(4):e2208. PubMed ID: 27124582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
